Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Opinion: More Tests Needed to Diagnose Fever of Unknown Origin

Alan Zalkowitz, MD  |  Issue: June 2016  |  June 13, 2016

I’m writing in regard to the article, “Fever of Unknown Origin” (TR, March 2016), by Charles Radis, DO. In regard to the non-caseating granulomas, there was no mention of epithelioid or giant cells. In addition, it was mainly [complement] C4 in the center of the granulomas, which is often found in sarcoidosis. Moreover, whether these were B cell positive, as in the granulomatous lesions of unknown significance syndrome, or B cell negative, as in sarcoidosis, is not reported.

From a diagnostic point of view, doing a Kveim-Siltzbach [test], which is positive in 80–90% of cases, would have been helpful. Over 40 years ago, when I started the rheumatology fellowship program at Mount Sinai in New York City, I heard Dr. Siltzbach—who with Alvin Tierstein ran the large sarcoidosis clinic—suggest that if you have muscle disease due to sarcoid, one always finds granulomas on biopsy. Perhaps, MRI of the muscle areas of the thighs with STIR [Short-TI Inversion Recovery] views might have shown the way for a muscle biopsy. As well, with synovial hypertrophy and active arthritis for many months, an MRI might have shown lesions of sarcoid or, at least, synovial inflammation, which on occasion—with a biopsy—would give the answer.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Alan Zalkowitz, MD
Fair Lawn, New Jersey

Share: 

Filed under:ConditionsProfessional Topics Tagged with:Diagnosisfeverpatient careRheumatic Diseaserheumatologist

Related Articles

    Case Report: Pulmonary Sarcoid-Like Reaction in Patient Treated with Etanercept

    April 15, 2022

    Sarcoidosis is a multisystem disease characterized by noncaseating granulomas in affected tissues, mostly involving the lungs and lymph nodes.1,2 The etiology of sarcoidosis remains unknown but is thought to be due to an inflammatory response to an antigen exposure in genetically predisposed individuals.1 Tumor necrosis factor-α (TNF‑α), a pro-inflammatory cytokine, plays an essential role in…

    Diagnosis Can Be Elusive for Fever of Unknown Origin

    Diagnosis Can Be Elusive for Fever of Unknown Origin

    March 15, 2016

    Settling into room 501 at Maine Medical Center, Mrs. N was on her way to the bathroom when she felt it coming on. One moment she was okay; the next, her chest felt damp and cold, even as her face flushed and her temperature spiked. Her forehead glistened beads of warm sweat. She felt the…

    Sarcoidosis in the Spotlight: Screening, Treatment & More Insights into Sarcoidosis

    June 1, 2021

    An expert discussed the screening and treatment of sarcoidosis and drug-induced sarcoidosis-like reactions during the 2021 ACR State-of-the-Art Clinical Symposium.

    Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

    November 1, 2013

    Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences